Tizanidine Tablet
Product Images NDC 76420-339

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Tizanidine (NDC 76420-339). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Asclemed Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Tizanidine-1 (Tizanidine 1)

Chemical structure diagram of Tizanidine hydrochloride, showing the molecular arrangement including a chlorine-substituted aromatic ring, thiazole, and imidazoline ring components.*

FDA Label Image

Tizanidine-2 (Tizanidine 2)

A line graph showing plasma Tizanidine concentration (ng/mL) over time (hours) after dosing. The graph compares four groups: 4 mg Tizanidine tablets with food, tablets without food, capsules with food, and capsules without food, illustrating how concentration changes during a 24-hour period post-dose.*

FDA Label Image

Tizanidine-3 (Tizanidine 3)

A line graph showing improvement in Ashworth Score over 6 hours post-dose for 16 mg tizanidine, 8 mg tizanidine, and placebo groups. The y-axis represents improvement score, and the x-axis shows hours post-dose with data points and error bars for each treatment.*

FDA Label Image

Tizanidine-4 (Tizanidine 4)

A line graph comparing improvement in Ashworth scores between tizanidine (mean dose 28.8 mg) and placebo groups at three study points: end of titration (week 3), end of maintenance (week 7), and study endpoint (last observation carried forward). The graph shows greater improvement (lower scores) with tizanidine versus placebo, with error bars indicating variability.*

FDA Label Image

Label (Label 2mg)

Packaging labels for Tizanidine Tablets USP 2 mg from Enovachem Pharmaceuticals, distributed by Sun Pharmaceutical Industries, Inc. The labels show various package quantities: 30, 60, 90, 150, and 1000 tablets. Each label includes NDC codes, storage instructions, a QR code, and caution statements regarding prescription dispensing.*

FDA Label Image

Label (Label 4mg)

Label images for Tizanidine Tablets, USP 4 mg, showing different package sizes including 30, 60, 90, 150, and 1000 tablets. Labels indicate packaging or relabeling by Enovachem Pharmaceuticals or Sun Pharmaceutical Industries, Inc., with registration and storage details. The tablets are described as white to off-white, round, flat beveled, uncoated.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.